Healthy Young People May Have to Wait Until 2022 for COVID Vaccine

Pfizer said that it may say if its vaccine is effective as soon as this month based on its 40,000-person clinical trial but that it also needs safety data that will not be available until November at the earliest

Pfizer said that it may say if its vaccine is effective as soon as this month based on its 40,000-person clinical trial but that it also needs safety data that will not be available until November at the earliest

If there's a sufficient supply, ME says it would have the capacity to vaccinate 80 percent of the state's 1.3 million people within 12 weeks of when a vaccine becomes available.

Pfizer Inc said on Friday it could file for US authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, suggesting it is possible a vaccine could be available in the United States this year.

Pfizer's predictions mean that its vaccine, called BNT162b2, may not be ready before the USA elections, as the president of the country, Donald Trump, had said on occasion, who stated that he expected this drug, of which he has already reserved 100 million doses, would be the first to be approved in the United States. "This protein is what the virus uses to penetrate the cells of our body and replicate ".

The World Health Organization (WHO) has identified 42 "candidate vaccines" at the stage of clinical trials, up from 11 in mid-June.

Sanofi SA and GlaxoSmithKline Plc are also working on developing a vaccine they say could be authorized next year. This disclosure did not appear to affect the development of the trials and the forecasts of both companies to obtain their vaccine against COVID-19 before the end of the year are maintained.

Another leading USA contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be November 25.

Use the form below to reset your password. AstraZeneca's US trial has been on hold since September, while another USA trial of a candidate from Johnson & Johnson was paused earlier this week.

All Blacks coach Ian Foster wields the axe for second Test
The bench also features Alex Hodgman, who could make his Test debut for the All Blacks . Prop Nepo Laulala returns via the bench alongside Hodgman.

"Here in Maine, we are planning for the arrival of a COVID-19 vaccine, whenever that might be", Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, said during his Thursday news conference.

But that is not necessarily bad news, said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.

In any case, they are unlikely to be a good substitute for wearing masks, social distancing, and other recommended behaviors to curb transmission, as how effective they will be is unknown at this time.

Pfizer is hoping to have a coronavirus vaccine ready for emergency use by late November.

There is some chance that a Covid-19 vaccine could be ready for the most vulnerable of the UK's population by Christmas, according to the head of the country's vaccine task force.

"What is different for COVID-19 vaccines is that speed of development and potential approval is much faster due to the public health emergency", noted the European Medicines Agency (EMA).

"Before approval, all vaccines in the European Union (EU) are evaluated against the same high standards as any other medicine", the EMA said in a statement.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.